-
Barr S D, Smiley J R, Bushman F D, 2008: The interferon response inhibits HIV particle production by induction of TRIM22[J]. PLoS Pathog, 4, e1000007-. doi: 10.1371/journal.ppat.1000007
-
Besse A, Lamothe B, Campos A D, Webster W K, Maddineni U, Lin S C, Wu H, Darnay B G, 2007: TAK1-dependent signaling requires functional interaction with TAB2/TAB3[J]. J Biol Chem, 282, 3918-3928.
-
Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel D V, 1996: TRAF6 is a signal transducer for interleukin-1[J]. Nature, 383, 443-446. doi: 10.1038/383443a0
-
Di Pietro A, Kajaste-Rudnitski A, Oteiza A, Nicora L, Towers G J, Mechti N, Vicenzi E, 2013: TRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation[J]. J Virol, 87, 4523-4533. doi: 10.1128/JVI.02548-12
-
Gao B, Duan Z, Xu W, Xiong S, 2009: Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain[J]. Hepatology, 50, 424-433.
-
Gong J, Shen X H, Qiu H, Chen C, Yang R G, 2011: Rhesus monkey TRIM5alpha represses HIV-1 LTR promoter activity by negatively regulating TAK1/TAB1/TAB2/TAB3-complex-mediated NF-kappaB activation[J]. Arch Virol, 156, 1997-2006. doi: 10.1007/s00705-011-1097-6
-
Gong J, Shen X H, Chen C, Qiu H, Yang R G, 2011: Down-regulation of HIV-1 infection by inhibition of the MAPK signaling pathway[J]. Virol Sin, 26, 114-122. doi: 10.1007/s12250-011-3184-y
-
Hayden M S, Ghosh S, 2008: Shared principles in NF-kappaB signaling[J]. Cell, 132, 344-362. doi: 10.1016/j.cell.2008.01.020
-
Huang F, Xiao H, Sun B L, Yang R G, 2013: Characterization of TRIM62 as a RING finger E3 ubiquitin ligase and its subcellular localization[J]. Biochem Biophys Res Commun, 432, 208-213. doi: 10.1016/j.bbrc.2013.02.012
-
Kanayama A, Seth R B, Sun L, Ea C K, Hong M, Shaito A, Chiu Y H, Deng L, Chen Z J, 2004: TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains[J]. Mol Cell, 15, 535-548. doi: 10.1016/j.molcel.2004.08.008
-
Kishida S, Sanjo H, Akira S, Matsumoto K, Ninomiya-Tsuji J, 2005: TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway[J]. Genes Cells, 10, 447-454. doi: 10.1111/j.1365-2443.2005.00852.x
-
Kuwayama K, Matsuzaki K, Mizobuchi Y, Mure H, Kitazato K T, Kageji T, Nakao M, Nagahiro S, 2009: Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma[J]. Neuro Oncol, 11, 132-141. doi: 10.1215/15228517-2008-083
-
McNab F W, Rajsbaum R, Stoye J P, O'Garra A, 2011: Tripartite-motif proteins and innate immune regulation[J]. 0Curr Opin Immunol, 23, 46-56. doi: 10.1016/j.coi.2010.10.021
-
Obad S, Olofsson T, Mechti N, Gullberg U, Drott K, 2007: Regulation of the interferon-inducible p53 target gene TRIM22 (Staf50) in human T lymphocyte activation[J]. J Interferon Cytokine Res, 27, 857-864. doi: 10.1089/jir.2006.0180
-
Obad S, Olofsson T, Mechti N, Gullberg U, Drott K, 2007: Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow[J]. Leuk Res, 31, 995-1001. doi: 10.1016/j.leukres.2006.12.012
-
Ozato K, Shin D M, Chang T H, Morse H C, 3 rd, 2008: TRIM family proteins and their emerging roles in innate immunity[J]. Nat Rev Immunol, 8, 849-860. doi: 10.1038/nri2413
-
Poole E, Groves I, MacDonald A, Pang Y, Alcami A, Sinclair J, 2009: Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus[J]. J Virol, 83, 3581-3590. doi: 10.1128/JVI.02072-08
-
Shi M, Deng W, Bi E, Mao K, Ji Y, Lin G, Wu X, Tao Z, Li Z, Cai X, Sun S, Xiang C, Sun B, 2008: TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation[J]. Nat Immunol, 9, 369-377. doi: 10.1038/ni1577
-
Sivaramakrishnan G, Sun Y, Rajmohan R, Lin V C, 2009: B30[J]. 2/SPRY domain in tripartite motif-containing 22 is essential for the formation of distinct nuclear bodies. FEBS Lett, 583, 2093-2099.
-
Tian Y, Zhang Y, Zhong B, Wang Y Y, Diao F C, Wang R P, Zhang M, Chen D Y, Zhai Z H, Shu H B, 2007: RBCK1 negatively regulates tumor necrosis factor-and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation[J]. J Biol Chem, 282, 16776-16782. doi: 10.1074/jbc.M701913200
-
Tissot C, Mechti N, 1995: Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression[J]. J Biol Chem, 270, 14891-14898. doi: 10.1074/jbc.270.25.14891
-
Wang C, Deng L, Hong M, Akkaraju G R, Inoue J, Chen Z J, 2001: TAK1 is a ubiquitin-dependent kinase of MKK and IKK[J]. Nature, 412, 346-351. doi: 10.1038/35085597
-
Wimmer N, Huber B, Wege A K, Barabas N, Rohrl J, Pfeffer K, Hehlgans T, 2012: Lymphotoxin-beta receptor activation on macrophages ameliorates acute DSS-induced intestinal inflammation in a TRIM30alpha-dependent manner[J]. Mol Immunol, 51, 128-135. doi: 10.1016/j.molimm.2012.02.118
-
Yu S, Gao B, Duan Z, Xu W, Xiong S, 2011: Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-kappaB activator[J]. Biochem Biophys Res Commun, 410, 247-251. doi: 10.1016/j.bbrc.2011.05.124
-
Zha J, Han K J, Xu L G, He W, Zhou Q, Chen D, Zhai Z, Shu H B, 2006: The Ret finger protein inhibits signaling mediated by the noncanonical and canonical IkappaB kinase family members[J]. J Immunol, 176, 1072-1080. doi: 10.4049/jimmunol.176.2.1072
-
Zhang X, Zhang J, Zhang L, van Dam H, ten Dijke P, 2013: UBE2O negatively regulates TRAF6-mediated NF-kappaB activation by inhibiting TRAF6 polyubiquitination[J]. Cell Res, 23, 366-377. doi: 10.1038/cr.2013.21
-
Zhong B, Zhang Y, Tan B, Liu T T, Wang Y Y, Shu H B, 2010: The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation[J]. J Immunol, 184, 6249-6255. doi: 10.4049/jimmunol.0903748
-
Zurek B, Schoultz I, Neerincx A, Napolitano L M, Birkner K, Bennek E, Sellge G, Lerm M, Meroni G, Soderholm J D, Kufer T A, 2012: TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation[J]. PLoS One, 7, e41255-. doi: 10.1371/journal.pone.0041255